Yale Cancer Center shared a post on X:
“Addressing obesity can help improve outcomes in breast cancer. A new study from Maryam Lustberg + Yale Breast Cancer colleagues finds no major safety concerns with GLP1 meds so far, but more research is needed on safe, effective, long-term weight loss options.”
Title: The Impact and Safety of GLP-1 Agents and Breast Cancer
Authors: Kayla Parsons, Mateo Montalvo, Neal Fischbach, Melissa Taylor, Salome Alfaro, Maryam Lustberg
You can read the Full Article on Cancer Medicine.
More posts featuring Breast Cancer on OncoDaily.